Teratogens: Causes and Effects of Birth Defects

Every year, millions of pregnancies around the world are affected by exposure to harmful agents that disrupt normal fetal development. These agents – known as teratogens – are responsible for a significant portion of congenital abnormalities that appear at birth. Between 2% and 3% of birth defects in the United States are classified as teratogen-induced malformations, resulting from environmental or iatrogenic exposures during pregnancy. Understanding what teratogens are, how they work, and what principles govern their effects is essential for anyone studying environmental health science or public health.

What are teratogens? 🔗

A teratogen is any environmental agent that causes abnormal development in an embryo or fetus during pregnancy. The term covers a wide range of agents, and teratogens are usually discovered after an increased prevalence of a particular birth defect is observed in a population. The word itself comes from the Greek “teras” (meaning monster) and “genesis” (meaning origin) – a dramatic etymology that reflects how severely these agents can alter development.

Teratogens may affect the embryo or fetus in multiple ways, causing physical malformations, problems in behavioral or emotional development, and decreased intellectual capacity in the child. They can also lead to complications like preterm labour, spontaneous abortions, and miscarriages.

Experts believe that teratogens can begin affecting a developing baby as early as 10 to 14 days after conception. Once the fertilised egg implants in the uterus, the mother and embryo share a blood supply, and harmful substances in the mother’s blood can then reach the growing baby.

How teratogens impact fetal development 🔗

During pregnancy, cells rapidly divide, differentiate, and organise into complex organ systems. This process requires precise timing and coordination. When a teratogen interferes with any step of this process – whether it’s cell division, cell migration, or tissue differentiation – the result can be a permanent structural or functional abnormality.

The risk from teratogen exposure is highest during the first eight weeks of pregnancy because many organs and systems are actively developing during this time. This period, known as organogenesis, is when the embryo is most sensitive. For example, the neural tube (which forms the brain and spine) closes within the first 3-5 weeks, and any disruption during that window can cause neural tube defects like spina bifida or anencephaly.

During the preimplantation phase (the first two weeks after conception), teratogenic exposure tends to follow an “all-or-none” pattern – either the embryo survives undamaged, or the pregnancy fails entirely. After this initial phase, vulnerability increases sharply.

The most common congenital abnormalities caused by teratogens include brain and spinal cord defects, structural malformations such as missing or underdeveloped limbs, cleft lip and palate, and heart defects.

Types of teratogens and their mechanisms 🔗

Teratogens are broadly classified into four categories: physical agents, metabolic conditions, infections, and drugs and chemicals. Each category has distinct mechanisms by which it disrupts normal embryonic development.

Drugs and chemical agents 🔗

Pharmaceutical drugs and recreational substances are among the most well-studied teratogens. A landmark example is thalidomide, a drug prescribed in the 1950s and early 1960s to treat morning sickness. It became apparent that thalidomide altered embryo development and led to limb deformities such as thumb absence, underdevelopment of entire limbs, or phocomelia, and may have caused teratogenic effects in over 10,000 babies worldwide.

The mechanism behind thalidomide’s effects is believed to involve the inhibition of blood vessel formation (antiangiogenesis) during the critical window of limb development. Other known teratogenic drugs include isotretinoin (used for severe acne), valproic acid (an anticonvulsant), methotrexate, and certain anticoagulants.

Alcohol is one of the most significant preventable teratogens. Drinking alcohol during pregnancy increases the risk for fetal alcohol syndrome, a disorder that can cause abnormal facial features, a small head and brain, and other physical and behavioural disabilities. There is no established safe amount of alcohol during pregnancy.

Tobacco is another major concern. Nicotine increases catecholamine release, which causes vasoconstriction of uteroplacental blood vessels, compromising blood flow and oxygen delivery to the fetus. This is linked to fetal growth restriction, premature birth, and increased risk of miscarriage.

Recreational drugs like cocaine cause similar vascular disruption. Using substances such as cocaine, methamphetamines, heroin, and marijuana during pregnancy can cause low birth weight, heart problems, and neonatal abstinence syndrome.

Infectious agents 🔗

Certain infections during pregnancy can cross the placental barrier and directly damage the developing fetus. These are often grouped under the acronym TORCH:

TORCH stands for Toxoplasmosis, Other (including syphilis and varicella), Rubella, Cytomegalovirus (CMV), and Herpes simplex virus. Each of these pathogens can cause a range of congenital defects depending on when infection occurs.

Rubella was one of the first human teratogens identified, discovered by Dr. Norman Gregg in 1941. Congenital rubella syndrome occurs in nearly all fetuses affected before 8 weeks of gestation, with few defects if maternal infection happens after 17 weeks. The virus causes damage through direct cytopathic effects and inhibition of cell division.

Cytomegalovirus (CMV) is currently the most common infectious cause of birth defects globally, potentially causing hearing loss, vision problems, and developmental delays. Toxoplasmosis, typically contracted through undercooked meat or contact with infected cat faeces, can cause a baby to be born with retinal lesions, hydrocephalus, and intracranial calcifications.

Generally, the earlier the exposure to an infectious teratogen during pregnancy, the more severe the congenital defects. Later infections tend to cause neonatal illness rather than structural malformations.

Physical agents 🔗

Ionising radiation – from X-rays, nuclear fallout, or radiation therapy – is a well-established physical teratogen. Ionising radiation can initiate gene mutations, chromosomal aberrations, mitotic interference, and enzyme inhibition. Depending on the dose and timing, radiation exposure can cause microcephaly, growth retardation, and an increased risk of childhood cancer.

Hyperthermia – abnormally elevated body temperature due to high fevers, hot tubs, or saunas – is another physical teratogen. Certain chemicals and heat sources that raise the mother’s body temperature can contribute to congenital abnormalities including spina bifida, cleft palate, or neurological problems.

Maternal metabolic conditions 🔗

Certain pre-existing health conditions in the mother can also act as teratogenic factors. Studies show the risk of fetal malformations rises from 4% to 10% in pregnancies where the mother has diabetes. Poorly controlled blood sugar during pregnancy has been linked to neural tube, brain, and spinal cord defects.

Universal pre-conception care for women with diabetes, combined with screening for undiagnosed diabetes in women of reproductive age, could prevent approximately 3,700 birth defects each year in the United States, with roughly $1.5 billion in averted lifetime costs.

Thyroid disorders and maternal nutritional deficiencies – particularly a lack of folic acid – are also significant metabolic teratogens. Daily supplementation with at least 400 micrograms of folic acid before and during early pregnancy is one of the most effective preventive measures against neural tube defects.

Wilson’s six principles of teratology 🔗

In 1959, embryologist James G. Wilson proposed a set of principles that would become the foundation of modern teratology. Wilson’s six principles, further refined in his 1973 monograph Environment and Birth Defects, guide research on teratogenic agents and their effects on developing organisms. These principles remain widely used in both research and teaching today.

Principle 1: Genetic susceptibility 🔗

Susceptibility to teratogenesis depends on the genotype of the conceptus and the manner in which this interacts with adverse environmental factors. This means that the genetic makeup of both the mother and the fetus determines how they respond to a teratogenic agent.

For example, variation in how a mother metabolises a particular drug will determine what metabolites the fetus is actually exposed to and for how long. Two mothers exposed to the same substance may have very different pregnancy outcomes based on their genetics. This is why less than 10% of infants exposed to hydantoins (common anticonvulsant drugs) actually develop congenital defects.

Principle 2: Timing of exposure 🔗

Susceptibility to teratogens varies significantly with the developmental stage at which exposure occurs. A high degree of sensitivity occurs during organogenesis, from approximately fetal age 18 to 60 days, with peak susceptibility at around 30 days.

Before cell differentiation begins, a severe insult either kills the embryo or causes no apparent damage (the “all-or-none” phenomenon). After organogenesis, teratogens are more likely to cause functional defects or growth retardation rather than major structural malformations. This principle explains why the same teratogen can cause entirely different defects depending on when the exposure occurs.

Principle 3: Mechanisms of action 🔗

Teratogenic agents act in specific ways on developing cells and tissues to initiate sequences of abnormal developmental events. These mechanisms include disrupting cell signalling, inhibiting enzymes, triggering mutations, causing cell death, and blocking normal cell migration.

Some teratogens are directly toxic and cause cell necrosis, while others trigger programmed cell death (apoptosis), alter patterns of gene expression, inhibit cell interactions, or block morphogenetic cell movements. Understanding the specific mechanism of a teratogen helps researchers develop targeted prevention strategies.

Principle 4: Access to developing tissues 🔗

Several factors affect the ability of a teratogen to contact a developing conceptus, including the nature of the agent itself, route and degree of maternal exposure, rate of placental transfer and systemic absorption, and composition of the maternal and embryonic genotypes.

A substance can only cause harm if it can reach the embryo. Some agents cross the placental barrier readily, while others are partially or fully blocked. The molecular size, lipid solubility, and chemical properties of a substance all determine how efficiently it reaches developing tissues.

Principle 5: Four manifestations of deviant development 🔗

Wilson’s fifth principle identifies four possible outcomes of teratogenic exposure: death, malformation, growth retardation, and functional deficit. Any encounter with a teratogenic agent has the potential to produce one or more of these outcomes.

The specific manifestation depends on the stage of development. After an embryo implants in the uterine wall but before its cells differentiate, the most common result is embryonic death. During organogenesis, structural malformations are most likely. Later in development, growth retardation and functional problems (such as intellectual disability or behavioural issues) become more probable outcomes.

Principle 6: Dose-response relationship 🔗

The manifestations of deviant development increase in frequency and degree as dosage increases, from the No Observable Adverse Effect Level (NOAEL) to a dose producing 100% lethality (LD100).

This principle establishes that teratogenic effects are dose-dependent. At very low doses, no observable effects may occur. As the dose increases, the likelihood and severity of birth defects rise proportionally. This concept is critical in toxicological risk assessment, as it helps researchers determine threshold levels below which a substance may not cause harm – though for some teratogens like alcohol, any safe threshold remains unestablished.

Why understanding teratogens matters 🔗

Nearly all teratogen-induced birth defects are preventable if the dose-response relationship for teratogen exposure and the teratogenic activity of the agent can be clearly defined. This makes teratology one of the most actionable areas of environmental health science.

Studies suggest that up to 80% of pregnant women are exposed to at least one medication or chemical during their pregnancy. Many of these exposures are avoidable with proper awareness, prenatal care, and medical guidance. Key prevention strategies include taking daily prenatal vitamins with folic acid, avoiding alcohol and tobacco, managing pre-existing conditions like diabetes, and staying up to date on vaccinations (particularly for rubella).

The principles laid out by Wilson over six decades ago continue to shape how scientists evaluate the safety of drugs, chemicals, and environmental agents. Recent advances in molecular and cellular biology only deepen our understanding of the developmental mechanisms that underlie Wilson’s principles. As our environment changes and new chemicals enter the market, the study of teratogens remains as relevant as ever.

What do you think? Given that many teratogen-induced birth defects are preventable, how effective do you believe current public health systems are at educating expectant parents about teratogenic risks? And should stricter regulations be placed on chemicals and pharmaceuticals that may pose risks to fetal development?

References

1. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6439a3.htm
2. https://www.intechopen.com/chapters/72507
3. https://rep.bioscientifica.com/view/journals/rep/146/5/R151.xml
4. https://www.ncbi.nlm.nih.gov/books/NBK545148/
5. https://www.ncbi.nlm.nih.gov/books/NBK132140/
6. https://www.jacionline.org/article/S0091-6749(99)70259-9/fulltext